MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
Clinical trial NCT04157686 · COMPLETED
Trial details
- NCT number
- NCT04157686
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2023-02-16
- Enrollment
- 957
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.